Idogen AB (publ) announced that Jan Holgersson, who has served for several years as scientific adviser to the company, has agreed to strengthen the company's Board of Directors in the role as co-opted Board member. Jan Holgersson is a professor of Transplant Immunology at Gothenburg University, the Medical Director of the Tissue Typing and Stem Cell Laboratories at Sahlgrenska University Hospital in Gothenburg, where he was also formerly the Head of Clinical Immunology and Transfusion Medicine. His research focuses on understanding the immunological mechanisms that underlie the rejection of transplanted organs and tissues.

Another important initiative has been supporting the development of diagnostics for detection and semiquantification of antibodies against the ABH blood group antigens and other tissue antigens (non-HLA). Jan Holgersson is also Chairman of the Board of VERIGRAFT AB, a Swedish biotech company. Jan has been part of the company's efforts at a detailed survey of the mechanisms of action for the company's technology platform.